Stryker Stock EBITDA
| SYK Stock | USD 325.43 2.02 0.62% |
Stryker fundamentals help investors to digest information that contributes to Stryker's financial success or failures. It also enables traders to predict the movement of Stryker Stock. The fundamental analysis module provides a way to measure Stryker's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Stryker stock.
Stryker |
Stryker Company EBITDA Analysis
Stryker's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Stryker EBITDA | 4.95 B |
Most of Stryker's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Stryker is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Stryker reported earnings before interest,tax, depreciation and amortization of 4.95 B. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 27.02% lower than that of the firm.
Stryker EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stryker's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Stryker could also be used in its relative valuation, which is a method of valuing Stryker by comparing valuation metrics of similar companies.Stryker is currently under evaluation in ebitda category among related companies.
Stryker Fundamentals
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0687 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.24 % | ||||
| Current Valuation | 138.84 B | ||||
| Shares Outstanding | 380.47 M | ||||
| Shares Owned By Insiders | 5.39 % | ||||
| Shares Owned By Institutions | 78.83 % | ||||
| Number Of Shares Shorted | 4.24 M | ||||
| Price To Earning | 63.07 X | ||||
| Price To Book | 7.00 X | ||||
| Price To Sales | 6.35 X | ||||
| Revenue | 20.5 B | ||||
| Gross Profit | 11.65 B | ||||
| EBITDA | 4.95 B | ||||
| Net Income | 3.17 B | ||||
| Cash And Equivalents | 1.84 B | ||||
| Cash Per Share | 2.98 X | ||||
| Total Debt | 12.99 B | ||||
| Debt To Equity | 0.88 % | ||||
| Current Ratio | 2.00 X | ||||
| Book Value Per Share | 48.92 X | ||||
| Cash Flow From Operations | 3.71 B | ||||
| Short Ratio | 3.74 X | ||||
| Earnings Per Share | 8.24 X | ||||
| Price To Earnings To Growth | 2.92 X | ||||
| Target Price | 372.04 | ||||
| Number Of Employees | 52 K | ||||
| Beta | 0.91 | ||||
| Market Capitalization | 128.47 B | ||||
| Total Asset | 39.91 B | ||||
| Retained Earnings | 16.77 B | ||||
| Working Capital | 4.6 B | ||||
| Current Asset | 1.15 B | ||||
| Current Liabilities | 707.5 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.07 % | ||||
| Net Asset | 39.91 B | ||||
| Last Dividend Paid | 3.05 |
About Stryker Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Stryker's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stryker using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stryker based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:Check out Stryker Piotroski F Score and Stryker Altman Z Score analysis. For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Stryker Stock analysis
When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is Stryker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.